Loading…
20,252 grants found
Showing 1,361 – 1,380 of 20,252 grants
PROJECT SUMMARY/ABSTRACT The Pathology Core will be co-led by Dr. Marisa Nucci, a pathologist with expertise in gynecologic neoplasia, and by Dr. Geoffrey Shapiro, who brings exper...
ABSTRACT Each year, 50.000 women are diagnosed with ductal carcinoma in situ (DCIS) in the US. DCIS is a non-invasive form of breast cancer, which respects the natural tissue barri...
Abstract Ovarian cancer remains the most lethal gynecological malignancy due to the lack of highly sensitive and specific screening tools for detection of early-stage disease. The...
SUMMARY Obesity increases the risk of numerous cancers including colorectal cancer (CRC). With the growing global epidemic of obesity, a greater understanding of the obesity cancer...
The goal of this research is to characterize Ras-driven and KSR1-dependent mechanisms that modulate tumor initiation, drug resistance and the epithelial-to-mesenchymal transition (...
PROJECT SUMMARY Current cell expansion procedures for antigen-specific CAR T cells and CAR NK cells result in cells with a broad repertoire of chemokine receptors. Upon infusion, t...
Project Summary Lung metastasis is the 2nd most common metastasis and accounts for 30% of all metastatic diseases in human cancer patients. Patients with lung metastases have a ver...
PROJECT SUMMARY Chromosomal Instability (CIN) and loss of the short arm of chromosome 17 (17p) are interrelated and relatively common characteristics of many advanced, metastatic c...
Project Summary Autologous chimeric antigen receptor T (CAR T) cell therapy poses logistical and economical challenges despite curative potential. Donor-derived allogeneic off-the-...
PROJECT SUMMARY/ABSTRACT Problem: Lung cancer is the third most common cancer in the US, with an estimated 238,340 new cases in 2023, and is projected to be about 2.5 times more de...
ABSTRACT Over the last decade, cell based “living medicines” like chimeric antigen receptor (CAR)-T cell immunotherapies have led to miraculous cures in advanced and aggressive leu...
Project Summary: The primary objective of this proposed research program is to evaluate in a clinical trial the improvements to clinical outcomes that the use of a software for sup...
Project Summary/Abstract Successful anti-tumor immune response requires coordination between the arms of immunity against multiple tumor antigens, as shown through studies of anima...
PROJECT SUMMARY/ABSTRACT Prostate cancer is the second-most diagnosed cancer and the second leading cause of cancer death in American men. Early detection of localized disease is c...
Project Summary Combinatorial screens characterize the molecular pathways of the cell by identifying interactions between perturbations. Quantifying interactions requires a notion...
PROJECT SUMMARY/ABSTRACT: PROJECT 1 – WEE1 inhibition in uterine serous carcinomas or p53-mutated uterine cancers Uterine serous carcinomas (USC) are a distinct histologic subtype...
Project Summary Microsatellite stable (MSS)/mismatch repair proficient (MMRP) uterine cancers (UCs) represent approximately two thirds (66%) of all UCs in The Cancer Genome Atlas (...
Project Summary The Administrative Core is led by Drs. Panagiotis Konstantinopoulos, Joyce Liu, and Ursula Matulonis who are in addition the Principal Investigators (PI)/Program Di...
Despite improvements in overall survival for most cancers, survival for patients with pancreatic cancer remains dismally low due to the late diagnosis and rapid spreading. Understa...
ABSTRACT Survivors of childhood cancer are at increased risk for chronic health conditions (CHCs) and early mortality at rates typically among individuals decades older, suggesting...